BAROZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 17.974
EU - Europa 7.878
AS - Asia 5.937
SA - Sud America 760
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 7
Totale 32.656
Nazione #
US - Stati Uniti d'America 17.808
GB - Regno Unito 3.065
CN - Cina 2.088
SG - Singapore 1.625
IT - Italia 1.483
HK - Hong Kong 989
SE - Svezia 913
BR - Brasile 635
DE - Germania 624
RU - Federazione Russa 391
UA - Ucraina 387
TR - Turchia 312
FI - Finlandia 308
VN - Vietnam 280
FR - Francia 189
KR - Corea 180
BG - Bulgaria 149
IN - India 126
CA - Canada 89
ID - Indonesia 72
NL - Olanda 69
AR - Argentina 51
JP - Giappone 47
BE - Belgio 43
CZ - Repubblica Ceca 38
IR - Iran 38
PL - Polonia 36
BD - Bangladesh 33
ES - Italia 33
IE - Irlanda 33
ZA - Sudafrica 33
MX - Messico 32
BZ - Belize 26
AT - Austria 24
LT - Lituania 24
IQ - Iraq 18
EC - Ecuador 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
EU - Europa 16
MY - Malesia 15
RO - Romania 15
MA - Marocco 13
PK - Pakistan 12
CO - Colombia 10
EG - Egitto 10
AZ - Azerbaigian 9
JO - Giordania 9
PY - Paraguay 9
CH - Svizzera 8
NP - Nepal 8
UZ - Uzbekistan 8
VE - Venezuela 8
AU - Australia 7
SK - Slovacchia (Repubblica Slovacca) 7
IL - Israele 6
KE - Kenya 6
PH - Filippine 6
CY - Cipro 5
GR - Grecia 5
RS - Serbia 5
SA - Arabia Saudita 5
UY - Uruguay 5
BO - Bolivia 4
DK - Danimarca 4
JM - Giamaica 4
KG - Kirghizistan 4
MD - Moldavia 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
TW - Taiwan 4
AL - Albania 3
LB - Libano 3
MK - Macedonia 3
NG - Nigeria 3
PS - Palestinian Territory 3
TH - Thailandia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
DZ - Algeria 1
Totale 32.638
Città #
Southend 2.310
Fairfield 1.978
Santa Clara 1.548
Ashburn 1.517
Woodbridge 1.279
Singapore 1.038
Hong Kong 983
Chandler 955
Houston 949
Ann Arbor 820
Jacksonville 781
Hefei 771
Seattle 736
Wilmington 696
Dearborn 655
Cambridge 589
Nyköping 504
London 376
Beijing 329
Los Angeles 329
Chicago 311
Modena 290
New York 268
Izmir 188
Seoul 163
San Diego 161
Buffalo 155
Princeton 149
Sofia 146
Helsinki 140
Eugene 139
Salt Lake City 120
The Dalles 119
Moscow 107
Munich 107
Milan 104
Dallas 97
Council Bluffs 96
Ho Chi Minh City 90
Fremont 89
Shanghai 74
Bremen 71
Des Moines 70
Hanoi 65
Rome 60
São Paulo 59
Tampa 58
Bologna 54
Elk Grove Village 53
San Jose 53
Columbus 52
Boardman 51
Jakarta 50
Redwood City 48
Brussels 40
Tokyo 40
Philadelphia 36
Albuquerque 32
Atlanta 32
Dublin 32
Turku 31
Brooklyn 30
Lancaster 29
Montreal 28
Kent 27
Orem 27
Toronto 27
Belize City 26
Las Vegas 26
Ottawa 26
Phoenix 25
Stockholm 24
Frankfurt am Main 23
Guangzhou 23
Nanjing 23
Denver 22
Norwalk 22
Leawood 21
Warsaw 21
Kunming 20
Reggio Emilia 20
San Mateo 20
Sterling 20
Verona 20
Dulles 19
Johannesburg 19
Tulare 19
Chennai 18
Paris 18
Rio de Janeiro 18
Boston 17
Da Nang 17
Jinan 17
Miami 17
Naples 17
San Francisco 17
Kilburn 16
Saint Louis 16
Chiswick 15
Washington 15
Totale 24.068
Nome #
HHV-6A in syncytial giant-cell hepatitis 423
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 406
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 384
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 377
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 358
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 341
B cells and herpesviruses: a model of lymphoproliferation 333
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 330
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 329
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 327
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 325
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 325
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 319
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 310
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 308
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 307
Acute appendicitis in adult neutropenic patients with hematologic malignancies 305
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 305
Translational challenges of human herpesvirus 6 chromosomal integration. 305
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 303
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 298
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 297
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 293
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 293
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 293
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 292
Mucorales-specific T cells in patients with hematologic malignancies 284
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 283
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 282
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 282
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 280
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 279
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 278
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 277
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 277
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 275
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 274
Parvoviruses in blood donors and transplant patients, Italy 274
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 269
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 266
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 265
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 263
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 258
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 258
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 255
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 254
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 253
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 250
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 249
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 241
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 240
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 239
Diagnosis of aspergillosis: Role of proteomics 239
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 239
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 238
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 232
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 231
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 231
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 230
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 230
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 230
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 229
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 228
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 226
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 226
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 226
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 225
How I treat HHV8/KSHV-related diseases in posttransplant patients. 224
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 224
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 221
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 218
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 218
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 218
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 216
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 215
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 214
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 213
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 213
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 212
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 211
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission 211
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 208
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 207
Late-appearing PML/RAR alpha fusion transcript with coincidental t(12;13)(p13.2;q14) in acute promyelocytic leukemia lacking the t(15;17) cytogenetic anomaly 206
Human herpesvirus 6 infection in normal human brain tissue 205
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 205
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 204
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 203
CHARACTERIZATION OF HUMAN HERPESVIRUS-6 GENOMES FROM CASES OF LATENT INFECTION IN HUMAN LYMPHOMAS AND IMMUNE DISORDERS 198
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 198
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 198
Human herpesvirus-6 genome in acute lymphoblastic leukemia: Evidence against an etiologic relationship 193
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 192
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 191
Human herpesvirus-6 (HHV-6) in blood donors 190
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 190
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 189
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 185
Spontaneous loss of Ph chromosome with maintenance of clonal hemopoiesis in an untreated patient with myeloproliferative disease and a long survival. 184
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 182
Totale 25.607
Categoria #
all - tutte 129.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.934 0 0 0 0 0 228 242 429 168 450 223 194
2021/20222.760 76 381 381 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/20255.820 248 71 101 426 1.053 832 454 324 609 240 617 845
2025/20265.697 814 507 1.072 1.219 1.812 273 0 0 0 0 0 0
Totale 32.945